

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.23311838 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.23311838 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.09715418 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.60121116 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.60121116 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.60121116 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.60121116 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.60121116 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.60121116 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.36947115 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.78297870 |
| 12 | detection of other organism (GO:0098543) | 4.74744214 |
| 13 | detection of bacterium (GO:0016045) | 4.67612840 |
| 14 | negative thymic T cell selection (GO:0045060) | 4.56364833 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54443216 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 4.53739788 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.53558765 |
| 18 | negative T cell selection (GO:0043383) | 4.50433880 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.21160162 |
| 20 | leukocyte aggregation (GO:0070486) | 4.17639657 |
| 21 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.16089145 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.14849918 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.07786863 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.02636824 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.97854783 |
| 26 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.91344304 |
| 27 | response to host immune response (GO:0052572) | 3.85634184 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.85634184 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.85264212 |
| 30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.81796434 |
| 31 | regulation of B cell differentiation (GO:0045577) | 3.76450309 |
| 32 | negative regulation of T cell mediated immunity (GO:0002710) | 3.75884801 |
| 33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.75735031 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.72722930 |
| 35 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.72255773 |
| 36 | ribosomal small subunit assembly (GO:0000028) | 3.68753231 |
| 37 | positive regulation of B cell differentiation (GO:0045579) | 3.67814646 |
| 38 | detection of molecule of bacterial origin (GO:0032490) | 3.65779517 |
| 39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.61308240 |
| 40 | response to interleukin-15 (GO:0070672) | 3.60667471 |
| 41 | positive thymic T cell selection (GO:0045059) | 3.59191571 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.55970006 |
| 43 | response to host (GO:0075136) | 3.55970006 |
| 44 | response to host defenses (GO:0052200) | 3.55970006 |
| 45 | thymic T cell selection (GO:0045061) | 3.55326523 |
| 46 | myeloid dendritic cell activation (GO:0001773) | 3.51751920 |
| 47 | detection of biotic stimulus (GO:0009595) | 3.50311090 |
| 48 | interferon-gamma production (GO:0032609) | 3.49431582 |
| 49 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.48336340 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 3.46269966 |
| 51 | negative regulation of phagocytosis (GO:0050765) | 3.43470946 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.42989671 |
| 53 | T cell migration (GO:0072678) | 3.40024397 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 3.36443685 |
| 55 | germinal center formation (GO:0002467) | 3.34764808 |
| 56 | cellular response to interleukin-15 (GO:0071350) | 3.34113660 |
| 57 | microglial cell activation (GO:0001774) | 3.33548303 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.32744819 |
| 59 | T cell selection (GO:0045058) | 3.32067521 |
| 60 | response to type I interferon (GO:0034340) | 3.30521419 |
| 61 | type I interferon signaling pathway (GO:0060337) | 3.30479308 |
| 62 | cellular response to type I interferon (GO:0071357) | 3.30479308 |
| 63 | myeloid dendritic cell differentiation (GO:0043011) | 3.30006950 |
| 64 | neutrophil activation involved in immune response (GO:0002283) | 3.28163069 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 3.27901537 |
| 66 | sequestering of actin monomers (GO:0042989) | 3.27077125 |
| 67 | B cell receptor signaling pathway (GO:0050853) | 3.26594498 |
| 68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.25917823 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.24638147 |
| 70 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.23954794 |
| 71 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.22704349 |
| 72 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.22431561 |
| 73 | negative regulation of cell killing (GO:0031342) | 3.22431561 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 3.22334057 |
| 75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.20575858 |
| 76 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.16660884 |
| 77 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.15719111 |
| 78 | cellular response to zinc ion (GO:0071294) | 3.14554607 |
| 79 | T cell homeostasis (GO:0043029) | 3.14244508 |
| 80 | neutrophil mediated immunity (GO:0002446) | 3.13973268 |
| 81 | positive regulation of mast cell activation (GO:0033005) | 3.13648986 |
| 82 | macrophage activation (GO:0042116) | 3.10867264 |
| 83 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.10145945 |
| 84 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.09585775 |
| 85 | B cell mediated immunity (GO:0019724) | 3.09428199 |
| 86 | positive regulation of interleukin-2 production (GO:0032743) | 3.08818934 |
| 87 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08281280 |
| 88 | mast cell activation (GO:0045576) | 3.07847675 |
| 89 | T cell costimulation (GO:0031295) | 3.07412601 |
| 90 | leukocyte degranulation (GO:0043299) | 3.04534486 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 3.03381804 |
| 92 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.02858613 |
| 93 | lymphocyte costimulation (GO:0031294) | 3.02831802 |
| 94 | negative regulation of innate immune response (GO:0045824) | 3.00872297 |
| 95 | regulation of mast cell activation (GO:0033003) | 3.00431753 |
| 96 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.98879101 |
| 97 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98247952 |
| 98 | regulation of necroptotic process (GO:0060544) | 2.97377854 |
| 99 | neutrophil activation (GO:0042119) | 2.96954640 |
| 100 | defense response to protozoan (GO:0042832) | 2.96102810 |
| 101 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.96021820 |
| 102 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.94448018 |
| 103 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93896746 |
| 104 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.93801330 |
| 105 | negative regulation of interleukin-6 production (GO:0032715) | 2.92630518 |
| 106 | positive regulation of interferon-alpha production (GO:0032727) | 2.92527805 |
| 107 | cellular response to interferon-beta (GO:0035458) | 2.91898901 |
| 108 | B cell homeostasis (GO:0001782) | 2.91199927 |
| 109 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.91019040 |
| 110 | regulation of leukocyte degranulation (GO:0043300) | 2.90543637 |
| 111 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90526138 |
| 112 | natural killer cell activation (GO:0030101) | 2.90491811 |
| 113 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.89692041 |
| 114 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.89692041 |
| 115 | actin nucleation (GO:0045010) | 2.89522372 |
| 116 | response to protozoan (GO:0001562) | 2.89370634 |
| 117 | positive T cell selection (GO:0043368) | 2.89266769 |
| 118 | regulation of response to interferon-gamma (GO:0060330) | 2.88899275 |
| 119 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.87618319 |
| 120 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.86872005 |
| 121 | T cell receptor signaling pathway (GO:0050852) | 2.83637093 |
| 122 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.83106233 |
| 123 | dendritic cell differentiation (GO:0097028) | 2.82791958 |
| 124 | leukocyte cell-cell adhesion (GO:0007159) | 2.82179566 |
| 125 | response to interferon-beta (GO:0035456) | 2.81721071 |
| 126 | regulation of RIG-I signaling pathway (GO:0039535) | 2.79393891 |
| 127 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.78207617 |
| 128 | response to muramyl dipeptide (GO:0032495) | 2.77896678 |
| 129 | natural killer cell differentiation (GO:0001779) | 2.76380978 |
| 130 | lymphocyte homeostasis (GO:0002260) | 2.75886416 |
| 131 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.74700753 |
| 132 | megakaryocyte development (GO:0035855) | 2.74396757 |
| 133 | regulation of tolerance induction (GO:0002643) | 2.73371374 |
| 134 | tolerance induction (GO:0002507) | 2.72369806 |
| 135 | granulocyte activation (GO:0036230) | 2.71535813 |
| 136 | positive regulation of macrophage differentiation (GO:0045651) | 2.69174193 |
| 137 | positive regulation of lamellipodium assembly (GO:0010592) | 2.68296616 |
| 138 | respiratory burst (GO:0045730) | 2.67709233 |
| 139 | regulation of natural killer cell differentiation (GO:0032823) | 2.66756971 |
| 140 | positive regulation of isotype switching (GO:0045830) | 2.64475236 |
| 141 | response to peptidoglycan (GO:0032494) | 2.64149513 |
| 142 | necroptotic process (GO:0070266) | 2.62983879 |
| 143 | mature B cell differentiation (GO:0002335) | 2.61687471 |
| 144 | leukocyte homeostasis (GO:0001776) | 2.61251296 |
| 145 | cellular extravasation (GO:0045123) | 2.56337320 |
| 146 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.54691926 |
| 147 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.54691926 |
| 148 | mature B cell differentiation involved in immune response (GO:0002313) | 2.54068229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.62759050 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.47554697 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.32988823 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.82552637 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.79526453 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.69561391 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.40720359 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.28453170 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.10456691 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.87404415 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.76971723 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.76445356 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.75413753 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.63088622 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.57801189 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.57571549 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52241400 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.47722687 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.46745354 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45809687 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.40563586 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.38549636 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.36130085 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27735063 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26204454 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.24021100 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18521915 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18337365 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17064809 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.16287495 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.12697375 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.10842172 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00623753 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.99105286 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97157533 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93995806 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86881672 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86508376 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84983456 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.83491106 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77821722 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72850814 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63634913 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60091003 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.56027203 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53426342 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.51557052 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50195995 |
| 49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.49847577 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48748605 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46081517 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45167234 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45160947 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45126337 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43061573 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39206417 |
| 57 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.38907920 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37377509 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36686744 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34602832 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.33342131 |
| 62 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.33094689 |
| 63 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.31971244 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31352017 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30132740 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29595729 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27906443 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26896676 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26397917 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25927070 |
| 71 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.25029479 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24015148 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23863658 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23021623 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22359098 |
| 76 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.21083720 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21025307 |
| 78 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20686726 |
| 79 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20490007 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16098471 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16027235 |
| 82 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.14742443 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12527136 |
| 84 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.12001178 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11606578 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10292747 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09954443 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08427666 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07281962 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06345185 |
| 91 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05155967 |
| 92 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.05096326 |
| 93 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05006683 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05004684 |
| 95 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04629285 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03051648 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02487267 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99636069 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99217611 |
| 100 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98932408 |
| 101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97101737 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97097866 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96190762 |
| 104 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95081260 |
| 105 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93809492 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93598253 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92881031 |
| 108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91285418 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90659485 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90374088 |
| 111 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.90171399 |
| 112 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89644640 |
| 113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88769490 |
| 114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88451883 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88348272 |
| 116 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87791280 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87273096 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86263163 |
| 119 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85155072 |
| 120 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.82176935 |
| 121 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.81802988 |
| 122 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.81667529 |
| 123 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.81341680 |
| 124 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80607324 |
| 125 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.80424040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.60095721 |
| 2 | MP0000685_abnormal_immune_system | 3.84322103 |
| 3 | MP0005671_abnormal_response_to | 3.53783127 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.25276482 |
| 5 | MP0003436_decreased_susceptibility_to | 3.05306209 |
| 6 | MP0009785_altered_susceptibility_to | 3.02298458 |
| 7 | MP0005387_immune_system_phenotype | 3.00172904 |
| 8 | MP0001790_abnormal_immune_system | 3.00172904 |
| 9 | MP0001800_abnormal_humoral_immune | 2.98353506 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.86019651 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.76031899 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.72660003 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.67495819 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.66014400 |
| 15 | MP0001819_abnormal_immune_cell | 2.65939097 |
| 16 | MP0002723_abnormal_immune_serum | 2.62665763 |
| 17 | MP0005025_abnormal_response_to | 2.60036440 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.59089733 |
| 19 | MP0002398_abnormal_bone_marrow | 2.53024283 |
| 20 | MP0002419_abnormal_innate_immunity | 2.39500610 |
| 21 | MP0000716_abnormal_immune_system | 2.25583033 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.25437889 |
| 23 | MP0002405_respiratory_system_inflammati | 2.23976058 |
| 24 | MP0001873_stomach_inflammation | 2.11141657 |
| 25 | MP0001853_heart_inflammation | 2.09924181 |
| 26 | MP0004510_myositis | 2.08221932 |
| 27 | MP0002006_tumorigenesis | 2.08214287 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.02487041 |
| 29 | MP0002722_abnormal_immune_system | 1.99728546 |
| 30 | MP0003303_peritoneal_inflammation | 1.99559326 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.97668505 |
| 32 | MP0002429_abnormal_blood_cell | 1.92722946 |
| 33 | MP0003724_increased_susceptibility_to | 1.90159049 |
| 34 | MP0006082_CNS_inflammation | 1.89669967 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.89412063 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.88734932 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.80711525 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.70715335 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.70715335 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.70538163 |
| 41 | MP0001348_abnormal_lacrimal_gland | 1.70107051 |
| 42 | MP0004947_skin_inflammation | 1.65555853 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.65416332 |
| 44 | MP0002933_joint_inflammation | 1.62647342 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.59070440 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.51649751 |
| 47 | MP0000490_abnormal_crypts_of | 1.51038711 |
| 48 | MP0005310_abnormal_salivary_gland | 1.50890881 |
| 49 | MP0008260_abnormal_autophagy | 1.49060139 |
| 50 | MP0003866_abnormal_defecation | 1.46617437 |
| 51 | MP0000858_altered_metastatic_potential | 1.45156657 |
| 52 | MP0004381_abnormal_hair_follicle | 1.44926975 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.44299996 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 1.42987644 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.41758392 |
| 56 | MP0005451_abnormal_body_composition | 1.38900727 |
| 57 | MP0009278_abnormal_bone_marrow | 1.33747158 |
| 58 | MP0003448_altered_tumor_morphology | 1.23822031 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.22647345 |
| 60 | MP0008469_abnormal_protein_level | 1.16505846 |
| 61 | MP0004883_abnormal_blood_vessel | 1.13792750 |
| 62 | MP0008007_abnormal_cellular_replicative | 1.12817118 |
| 63 | MP0008057_abnormal_DNA_replication | 1.10904731 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.03427858 |
| 65 | MP0003075_altered_response_to | 1.03251558 |
| 66 | MP0003045_fibrosis | 0.96400185 |
| 67 | MP0000343_altered_response_to | 0.96392493 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 0.96092056 |
| 69 | MP0002163_abnormal_gland_morphology | 0.95886041 |
| 70 | MP0005058_abnormal_lysosome_morphology | 0.94201792 |
| 71 | MP0003077_abnormal_cell_cycle | 0.92394135 |
| 72 | MP0003172_abnormal_lysosome_physiology | 0.92340770 |
| 73 | MP0005166_decreased_susceptibility_to | 0.91208663 |
| 74 | MP0002009_preneoplasia | 0.89898647 |
| 75 | MP0002095_abnormal_skin_pigmentation | 0.89857064 |
| 76 | MP0006054_spinal_hemorrhage | 0.88092094 |
| 77 | MP0009764_decreased_sensitivity_to | 0.86311603 |
| 78 | MP0005023_abnormal_wound_healing | 0.85540495 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.85480651 |
| 80 | MP0005164_abnormal_response_to | 0.84990348 |
| 81 | MP0010094_abnormal_chromosome_stability | 0.82397353 |
| 82 | MP0003693_abnormal_embryo_hatching | 0.81775505 |
| 83 | MP0002132_abnormal_respiratory_system | 0.81126812 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.80909068 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.79721327 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.78927810 |
| 87 | MP0010307_abnormal_tumor_latency | 0.74858842 |
| 88 | MP0001851_eye_inflammation | 0.74359425 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.72415779 |
| 90 | MP0003279_aneurysm | 0.71793701 |
| 91 | MP0005390_skeleton_phenotype | 0.71442304 |
| 92 | MP0002877_abnormal_melanocyte_morpholog | 0.70523865 |
| 93 | MP0003091_abnormal_cell_migration | 0.66787368 |
| 94 | MP0000313_abnormal_cell_death | 0.66699574 |
| 95 | MP0000604_amyloidosis | 0.66239889 |
| 96 | MP0003690_abnormal_glial_cell | 0.63544767 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.62582162 |
| 98 | MP0009763_increased_sensitivity_to | 0.62239172 |
| 99 | MP0008058_abnormal_DNA_repair | 0.62073248 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 0.61975310 |
| 101 | MP0002254_reproductive_system_inflammat | 0.61960081 |
| 102 | MP0008874_decreased_physiological_sensi | 0.61025082 |
| 103 | MP0000249_abnormal_blood_vessel | 0.60262541 |
| 104 | MP0001663_abnormal_digestive_system | 0.59718980 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.59278440 |
| 106 | MP0003795_abnormal_bone_structure | 0.58269840 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.58030970 |
| 108 | MP0008004_abnormal_stomach_pH | 0.57977062 |
| 109 | MP0003828_pulmonary_edema | 0.57788499 |
| 110 | MP0003943_abnormal_hepatobiliary_system | 0.57321647 |
| 111 | MP0009840_abnormal_foam_cell | 0.55821189 |
| 112 | MP0003111_abnormal_nucleus_morphology | 0.54711831 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.54684838 |
| 114 | MP0004957_abnormal_blastocyst_morpholog | 0.54496760 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.54474659 |
| 116 | MP0000350_abnormal_cell_proliferation | 0.53849009 |
| 117 | MP0001243_abnormal_dermal_layer | 0.53088596 |
| 118 | MP0002928_abnormal_bile_duct | 0.52103655 |
| 119 | MP0005381_digestive/alimentary_phenotyp | 0.47919265 |
| 120 | MP0000371_diluted_coat_color | 0.45754955 |
| 121 | MP0000609_abnormal_liver_physiology | 0.43552699 |
| 122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.43191669 |
| 123 | MP0003806_abnormal_nucleotide_metabolis | 0.40628082 |
| 124 | MP0004130_abnormal_muscle_cell | 0.40154098 |
| 125 | MP0002133_abnormal_respiratory_system | 0.39369460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.27879744 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.99075681 |
| 3 | Chronic otitis media (HP:0000389) | 4.91679718 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.85025621 |
| 5 | Myositis (HP:0100614) | 4.78698922 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.48889530 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.34708726 |
| 8 | Thrombocytosis (HP:0001894) | 4.26572400 |
| 9 | Recurrent viral infections (HP:0004429) | 4.11925227 |
| 10 | IgM deficiency (HP:0002850) | 4.08425212 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.05091605 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.00423485 |
| 13 | Nasal polyposis (HP:0100582) | 3.71403074 |
| 14 | Abnormality of T cell number (HP:0011839) | 3.63948567 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.59554768 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.59554768 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.54471192 |
| 18 | Abnormality of T cells (HP:0002843) | 3.50156397 |
| 19 | Recurrent skin infections (HP:0001581) | 3.49433927 |
| 20 | T lymphocytopenia (HP:0005403) | 3.43973494 |
| 21 | Abnormality of the nasal mucosa (HP:0000433) | 3.37944111 |
| 22 | Meningitis (HP:0001287) | 3.36365570 |
| 23 | Orchitis (HP:0100796) | 3.35830451 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.33875508 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 3.27648941 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.21055953 |
| 27 | Optic neuritis (HP:0100653) | 3.21055953 |
| 28 | Vasculitis (HP:0002633) | 3.19999137 |
| 29 | Cellulitis (HP:0100658) | 3.19213978 |
| 30 | Increased IgM level (HP:0003496) | 3.18331008 |
| 31 | Agammaglobulinemia (HP:0004432) | 3.15178592 |
| 32 | Hypochromic anemia (HP:0001931) | 3.14433992 |
| 33 | Hypochromic microcytic anemia (HP:0004840) | 3.13660028 |
| 34 | Petechiae (HP:0000967) | 3.12755475 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 3.10833399 |
| 36 | IgG deficiency (HP:0004315) | 3.05123526 |
| 37 | Obstructive lung disease (HP:0006536) | 3.04330489 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04330489 |
| 39 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.04205244 |
| 40 | Lymphopenia (HP:0001888) | 2.99559922 |
| 41 | Abnormality of macrophages (HP:0004311) | 2.99422464 |
| 42 | Leukocytosis (HP:0001974) | 2.92601774 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.91866936 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.91129235 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.90095775 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.87929524 |
| 47 | Eosinophilia (HP:0001880) | 2.85932570 |
| 48 | Episodic fever (HP:0001954) | 2.79881397 |
| 49 | Granulocytopenia (HP:0001913) | 2.74147633 |
| 50 | Increased IgE level (HP:0003212) | 2.67808981 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.65802243 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.65304942 |
| 53 | Abnormality of eosinophils (HP:0001879) | 2.64282547 |
| 54 | Pustule (HP:0200039) | 2.62166774 |
| 55 | Encephalitis (HP:0002383) | 2.62123567 |
| 56 | Stomatitis (HP:0010280) | 2.59755888 |
| 57 | Anorexia (HP:0002039) | 2.56352133 |
| 58 | Chronic sinusitis (HP:0011109) | 2.56159422 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.56007545 |
| 60 | Severe combined immunodeficiency (HP:0004430) | 2.55001211 |
| 61 | Sepsis (HP:0100806) | 2.53642172 |
| 62 | Fatigue (HP:0012378) | 2.51732711 |
| 63 | Pulmonary embolism (HP:0002204) | 2.51666025 |
| 64 | Arterial thrombosis (HP:0004420) | 2.47533012 |
| 65 | Colitis (HP:0002583) | 2.46644064 |
| 66 | Hemoptysis (HP:0002105) | 2.44377713 |
| 67 | IgA deficiency (HP:0002720) | 2.43298849 |
| 68 | Chronic diarrhea (HP:0002028) | 2.42931073 |
| 69 | Combined immunodeficiency (HP:0005387) | 2.42805651 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.41908781 |
| 71 | Thyroiditis (HP:0100646) | 2.39988520 |
| 72 | Epistaxis (HP:0000421) | 2.39718044 |
| 73 | Aplastic anemia (HP:0001915) | 2.37629746 |
| 74 | Chest pain (HP:0100749) | 2.36740050 |
| 75 | Peritonitis (HP:0002586) | 2.36624999 |
| 76 | Microcytic anemia (HP:0001935) | 2.36225116 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.34914884 |
| 78 | Lymphoma (HP:0002665) | 2.34479740 |
| 79 | Restrictive lung disease (HP:0002091) | 2.33240593 |
| 80 | Abnormality of the fingertips (HP:0001211) | 2.33181596 |
| 81 | Periodontitis (HP:0000704) | 2.27400839 |
| 82 | Gingivitis (HP:0000230) | 2.24240875 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 2.23900061 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 2.22485541 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 2.22428326 |
| 86 | Skin ulcer (HP:0200042) | 2.21386897 |
| 87 | Gangrene (HP:0100758) | 2.17409060 |
| 88 | Emphysema (HP:0002097) | 2.15210472 |
| 89 | Keratoconjunctivitis (HP:0001096) | 2.14485228 |
| 90 | Gingival bleeding (HP:0000225) | 2.13788081 |
| 91 | Viral hepatitis (HP:0006562) | 2.13581882 |
| 92 | Bronchitis (HP:0012387) | 2.13564640 |
| 93 | Amaurosis fugax (HP:0100576) | 2.12327050 |
| 94 | Gastrointestinal stroma tumor (HP:0100723) | 2.12298695 |
| 95 | Purpura (HP:0000979) | 2.12229067 |
| 96 | B lymphocytopenia (HP:0010976) | 2.10915139 |
| 97 | Abnormality of B cell number (HP:0010975) | 2.10915139 |
| 98 | Urticaria (HP:0001025) | 2.10301104 |
| 99 | Amyloidosis (HP:0011034) | 2.07825279 |
| 100 | Premature loss of primary teeth (HP:0006323) | 2.07712920 |
| 101 | Osteomyelitis (HP:0002754) | 2.07204939 |
| 102 | Skin rash (HP:0000988) | 2.06753811 |
| 103 | Glomerulopathy (HP:0100820) | 2.05032352 |
| 104 | Arthralgia (HP:0002829) | 2.04570336 |
| 105 | Abnormality of the prostate (HP:0008775) | 2.04284886 |
| 106 | Reticulocytopenia (HP:0001896) | 2.03087004 |
| 107 | Gastrointestinal infarctions (HP:0005244) | 2.02618220 |
| 108 | Keratitis (HP:0000491) | 1.99957485 |
| 109 | Papilloma (HP:0012740) | 1.99526558 |
| 110 | Verrucae (HP:0200043) | 1.99526558 |
| 111 | Abnormal platelet volume (HP:0011876) | 1.99440640 |
| 112 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.98913498 |
| 113 | Joint swelling (HP:0001386) | 1.97892198 |
| 114 | Recurrent sinusitis (HP:0011108) | 1.97635710 |
| 115 | Recurrent lower respiratory tract infections (HP:0002783) | 1.96919787 |
| 116 | Abnormality of the endocardium (HP:0004306) | 1.95879409 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 1.94041450 |
| 118 | Acute hepatic failure (HP:0006554) | 1.93716429 |
| 119 | Impaired platelet aggregation (HP:0003540) | 1.93551617 |
| 120 | Abnormal platelet function (HP:0011869) | 1.93551617 |
| 121 | Hematochezia (HP:0002573) | 1.91314775 |
| 122 | Abnormality of the pericardium (HP:0001697) | 1.91117247 |
| 123 | Hypertensive crisis (HP:0100735) | 1.89960506 |
| 124 | Hepatosplenomegaly (HP:0001433) | 1.88254263 |
| 125 | Recurrent pneumonia (HP:0006532) | 1.85865276 |
| 126 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.84964011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.62713658 |
| 2 | TXK | 3.33366646 |
| 3 | JAK3 | 2.96473320 |
| 4 | TYK2 | 2.90472431 |
| 5 | PRPF4B | 2.73763102 |
| 6 | MAP3K14 | 2.64087959 |
| 7 | KIT | 2.62402026 |
| 8 | ZAP70 | 2.52064181 |
| 9 | BLK | 2.44570438 |
| 10 | TBK1 | 2.42419590 |
| 11 | IRAK4 | 2.31457851 |
| 12 | BTK | 2.22125085 |
| 13 | STK10 | 2.20848280 |
| 14 | IKBKE | 2.13815996 |
| 15 | IKBKB | 1.90951667 |
| 16 | TEC | 1.85603097 |
| 17 | EEF2K | 1.83179158 |
| 18 | CSF1R | 1.82821634 |
| 19 | TESK2 | 1.80596653 |
| 20 | SYK | 1.80427388 |
| 21 | FLT3 | 1.74654082 |
| 22 | ITK | 1.70855690 |
| 23 | PIM2 | 1.62243842 |
| 24 | NME2 | 1.61847745 |
| 25 | JAK1 | 1.59122581 |
| 26 | TAOK1 | 1.59006122 |
| 27 | MAP3K11 | 1.55168263 |
| 28 | LCK | 1.52927540 |
| 29 | LRRK2 | 1.51624718 |
| 30 | MAP3K3 | 1.51494392 |
| 31 | SMG1 | 1.50769676 |
| 32 | MAP3K13 | 1.47118590 |
| 33 | GRK6 | 1.45838890 |
| 34 | FGFR4 | 1.45474941 |
| 35 | EPHB1 | 1.40858224 |
| 36 | FGR | 1.40689868 |
| 37 | KDR | 1.39946211 |
| 38 | RPS6KA4 | 1.34640020 |
| 39 | HCK | 1.28448085 |
| 40 | CSK | 1.27307954 |
| 41 | CLK1 | 1.25106278 |
| 42 | PIM1 | 1.22655809 |
| 43 | TGFBR2 | 1.21687050 |
| 44 | NLK | 1.21172424 |
| 45 | ERN1 | 1.20641409 |
| 46 | CHUK | 1.18748337 |
| 47 | MAP3K10 | 1.18681621 |
| 48 | PRKD2 | 1.11845921 |
| 49 | MAP2K3 | 1.10136160 |
| 50 | MAP3K1 | 1.08090926 |
| 51 | TGFBR1 | 1.05242977 |
| 52 | LYN | 1.02975473 |
| 53 | FGFR3 | 1.02244090 |
| 54 | MST4 | 1.00650038 |
| 55 | TESK1 | 0.97346272 |
| 56 | TAOK2 | 0.95982776 |
| 57 | SCYL2 | 0.95524098 |
| 58 | PKN2 | 0.93532460 |
| 59 | KSR2 | 0.93202760 |
| 60 | FES | 0.92826087 |
| 61 | TRIB3 | 0.92129926 |
| 62 | YES1 | 0.91124623 |
| 63 | ACVR1B | 0.86318667 |
| 64 | MARK2 | 0.86015097 |
| 65 | EPHA3 | 0.85371034 |
| 66 | PDK1 | 0.84731904 |
| 67 | IRAK1 | 0.84153629 |
| 68 | SIK3 | 0.80251658 |
| 69 | TRPM7 | 0.76202070 |
| 70 | MAPK12 | 0.73658959 |
| 71 | BMPR2 | 0.73013991 |
| 72 | CDK19 | 0.72313074 |
| 73 | EIF2AK1 | 0.70927465 |
| 74 | MAP3K12 | 0.70523941 |
| 75 | CDC42BPA | 0.68666049 |
| 76 | SIK2 | 0.68418593 |
| 77 | RIPK4 | 0.67989720 |
| 78 | MAPK7 | 0.66657475 |
| 79 | JAK2 | 0.66396076 |
| 80 | MAPKAPK2 | 0.65496331 |
| 81 | RPS6KB2 | 0.64020881 |
| 82 | PDPK1 | 0.63255313 |
| 83 | STK4 | 0.61651881 |
| 84 | IRAK2 | 0.61128831 |
| 85 | PTK2B | 0.60024988 |
| 86 | MAP3K7 | 0.58663772 |
| 87 | FYN | 0.57910870 |
| 88 | PAK4 | 0.57498137 |
| 89 | SIK1 | 0.57480702 |
| 90 | TAOK3 | 0.57262565 |
| 91 | PRKCQ | 0.56631638 |
| 92 | MATK | 0.55581217 |
| 93 | MARK3 | 0.54902414 |
| 94 | MAP3K8 | 0.54549902 |
| 95 | RPS6KA6 | 0.52600352 |
| 96 | NEK2 | 0.52589630 |
| 97 | CDK4 | 0.51832811 |
| 98 | IRAK3 | 0.49319221 |
| 99 | PRKCH | 0.46456296 |
| 100 | PTK6 | 0.46177694 |
| 101 | TTN | 0.45375144 |
| 102 | BUB1 | 0.44625505 |
| 103 | NEK9 | 0.44029514 |
| 104 | TNK2 | 0.43849982 |
| 105 | CAMKK1 | 0.43825664 |
| 106 | STK11 | 0.43514004 |
| 107 | DYRK3 | 0.43222853 |
| 108 | VRK1 | 0.42294736 |
| 109 | MAPK4 | 0.40817379 |
| 110 | RPS6KA5 | 0.39685589 |
| 111 | PIK3CG | 0.39606948 |
| 112 | ILK | 0.39244405 |
| 113 | MAP2K6 | 0.39142999 |
| 114 | MAPK11 | 0.37723092 |
| 115 | PRKCD | 0.36852460 |
| 116 | MAP3K5 | 0.36345479 |
| 117 | RPS6KC1 | 0.36144393 |
| 118 | RPS6KL1 | 0.36144393 |
| 119 | HIPK2 | 0.35883206 |
| 120 | PASK | 0.34127085 |
| 121 | SGK3 | 0.33354973 |
| 122 | ATR | 0.32864692 |
| 123 | ABL1 | 0.32707098 |
| 124 | CDK6 | 0.31769356 |
| 125 | EIF2AK3 | 0.31504958 |
| 126 | DYRK1B | 0.30996471 |
| 127 | MAP2K2 | 0.30229804 |
| 128 | BRSK2 | 0.30071654 |
| 129 | MAPKAPK3 | 0.29687785 |
| 130 | EIF2AK2 | 0.29661646 |
| 131 | RAF1 | 0.29655279 |
| 132 | CAMKK2 | 0.28491687 |
| 133 | CDC7 | 0.28397856 |
| 134 | CDK12 | 0.27648776 |
| 135 | DAPK2 | 0.25932976 |
| 136 | RET | 0.24495790 |
| 137 | LIMK1 | 0.23672279 |
| 138 | MAPK3 | 0.23176675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.47167123 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.65228735 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.49246486 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.40747297 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.38584866 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.36162712 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.27309292 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16289520 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03724580 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02626930 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.00161274 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99995079 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.98084066 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96657683 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.94059380 |
| 16 | Shigellosis_Homo sapiens_hsa05131 | 1.80067815 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78035800 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76704210 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.74890212 |
| 20 | Ribosome_Homo sapiens_hsa03010 | 1.69994108 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.66826211 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66315910 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64915276 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61112011 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49949124 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48836168 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.47572864 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47554510 |
| 29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46061454 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.44433657 |
| 31 | Base excision repair_Homo sapiens_hsa03410 | 1.40741668 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.39355214 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33084448 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32762888 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.31555030 |
| 36 | Mismatch repair_Homo sapiens_hsa03430 | 1.31108179 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.30937161 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30843569 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29148186 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28615245 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.21777774 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.20852983 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20542432 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20256959 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.18726859 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.17853390 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10773186 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 1.10524596 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.10011199 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.09586186 |
| 51 | Asthma_Homo sapiens_hsa05310 | 1.07316461 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01346328 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.99605390 |
| 54 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98078044 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97626560 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.97090751 |
| 57 | Spliceosome_Homo sapiens_hsa03040 | 0.96523472 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96387673 |
| 59 | Homologous recombination_Homo sapiens_hsa03440 | 0.93065407 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90198762 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86949168 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86702564 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85942078 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83958889 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83039042 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 0.81565462 |
| 67 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.80359584 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.79507296 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79504925 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75550427 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74935433 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73344775 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72183358 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70784345 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69596579 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61428073 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59930115 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58646388 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56837010 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56568817 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55991863 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53543931 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.52846986 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51599015 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50281579 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50032431 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50029554 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49989043 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49394434 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49038128 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.48422786 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.47750750 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47695989 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47574230 |
| 95 | RNA polymerase_Homo sapiens_hsa03020 | 0.47423792 |
| 96 | RNA transport_Homo sapiens_hsa03013 | 0.47166780 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46058136 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45936369 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45289471 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.45230462 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43067462 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42205421 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.41959271 |
| 104 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39963344 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39876091 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.38107586 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36891923 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36465478 |
| 109 | Prostate cancer_Homo sapiens_hsa05215 | 0.36446814 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35932703 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35454243 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.35257683 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34503741 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34486665 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34244162 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33813633 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33720139 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.32104205 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31843966 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31127366 |
| 121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31054326 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30143354 |
| 123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30083723 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29988702 |
| 125 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29740037 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27817701 |

